Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection

Systematic Review: Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza

(2013) Nayer Khazeni et al.   ANNALS OF INTERNAL MEDICINE

Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses

(2010) Mariana Baz et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Changes in Prescribing of Antiviral Medications for Influenza Associated With New Treatment Guidelines

(2009) Adam L. Hersh et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Animal models for the study of influenza pathogenesis and therapy

(2009) Dale L. Barnard   ANTIVIRAL RESEARCH

Influenza Virus Resistance to Antiviral Agents: A Plea for Rational Use

(2009) Gregory A. Poland et al.   CLINICAL INFECTIOUS DISEASES

Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children

(2009) Iain Stephenson et al.   CLINICAL INFECTIOUS DISEASES

Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir- Resistant Influenza A(H1N1) Virus

(2009) Jairo Gooskens   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Evolution of Influenza Resistance and Treatment

(2009) David M. Weinstock   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States

(2009) Nila J. Dharan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis

(2009) Jane Burch et al.   LANCET INFECTIOUS DISEASES

Emergence and pandemic potential of swine-origin H1N1 influenza virus

(2009) Gabriele Neumann et al.   NATURE

Global Transmission of Oseltamivir-Resistant Influenza

(2009) Anne Moscona   NEW ENGLAND JOURNAL OF MEDICINE

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

(2009) Mariana Baz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adsorption of Human Papillomavirus 16 to Live Human Sperm

(2009) Julio Pérez-Andino et al.   PLoS One

A Randomized, Placebo-Controlled Trial to Assess the Safety and Acceptability of Use of Carraguard Vaginal Gel by Heterosexual Couples in Thailand

(2009) PETER H. KILMARX et al.   SEXUALLY TRANSMITTED DISEASES

The origin and global emergence of adamantane resistant A/H3N2 influenza viruses

(2009) Martha I. Nelson et al.   VIROLOGY

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

(2008) T. G. Sheu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?

(2008) Frederick Hayden   CLINICAL INFECTIOUS DISEASES

Focus on antivirally active sulfated polysaccharides: From structure–activity analysis to clinical evaluation

(2008) Tuhin Ghosh et al.   GLYCOBIOLOGY

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

(2008) Stephanie Skoler-Karpoff et al.   LANCET

Structure and mechanism of the M2 proton channel of influenza A virus

(2008) Jason R. Schnell et al.   NATURE

Efficacy of Carraguard®-Based Microbicides In Vivo Despite Variable In Vitro Activity

(2008) Stuart G. Turville et al.   PLoS One

Iota-Carrageenan is a potent inhibitor of rhinovirus infection

(2008) Andreas Grassauer et al.   Virology Journal

Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to Oseltamivir

(2008) Marie-Anne Rameix-Welti et al.   PLoS Pathogens